88 filings
Page 3 of 5
8-K
owhw4k wk2ztgjdjcdn
27 Aug 20
Trial Did Not Meet Primary Endpoint Believed to be the Result of BOTOX Not Effectively Permeating the Urothelium
8:01am
8-K
tasxieb
10 Aug 20
UroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
7:20am
8-K
poskr0n 9oznb6ti3x
10 Jun 20
Changes in Registrant's Certifying Accountant
4:16pm
8-K
a027 yrqd1
15 May 20
Other Events
9:17am
8-K
8r3662ylh
15 Apr 20
Other Events
9:29pm
8-K
aqvyhsj 4iy9z
23 Mar 20
Departure of Directors or Certain Officers
7:31am
8-K
6rwuqmqcx r2
20 Dec 19
Other Events
4:31pm
8-K
9vp5iiu2w63hsodq5t
22 Nov 19
Regulation FD Disclosure
4:16pm
8-K
wfdmnls7h808e 2eul4
12 Nov 19
UroGen Pharma Reports Third Quarter 2019 Financial Results and Recent
8:06am
8-K
lmp8lnla6x3 z6fuq
12 Nov 19
Entry into a Material Definitive Agreement
7:01am
8-K
7i8w1hxzsri8 h5
8 Nov 19
Entry into a Material Definitive Agreement
4:02pm
8-K
wom4526f71qh9g0w1
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
8-K
u5rpz
9 Aug 19
UroGen Pharma Reports Second Quarter 2019 Financial Results and Recent
8:16am
8-K
xsfg8qfk
7 Jun 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
nm0wf
28 May 19
Other Events
5:00pm
8-K
xn8c 1hy1f8vnumr
9 May 19
UroGen Pharma Reports First Quarter 2019 Financial Results and Recent
8:12am
8-K
argcl w8st65uhznna
28 Feb 19
UroGen Pharma to Report Fourth Quarter and Full Year 2018 Financial Results
8:16am
8-K
dgnwkondl6
25 Jan 19
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
7:30am
8-K
rrrl476vnol2w1emuzme
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm
8-K
ye5cd5c
9 Jan 19
UroGen Pharma Announces Positive Results ofUGN-101 from Pivotal
12:48pm